2 ms·
Yes that's fair, but the risk profile from the vaccine is also not just relegated to myocarditis, that's just what's been getting attention. It will probably be
by naasking 5y ago
Yes that's fair, but the risk profile from the vaccine is also not just relegated to myocarditis, that's just what's been getting attention. It will probably be years before we have an accurate risk assessment of both infection and vaccines. Given the availability of vaccines, it still makes sense to be choosier if you're in a potentially vulnerable population, which is what the paper suggests.